Since active targeting can significantly improve the target accumulation efficiency of a nanotheragnostic agent, Zhou et al. exploited a dual peptide (RGD and beclin 1) for target-specific autophagy-induced photothermal tumor ablation [112]. This evidence concerns the gene BECN1 and neoplasm.